59 results
8-K
ODYY
Odyssey Health, Inc.
29 Dec 23
Completion of Acquisition or Disposition of Assets
9:00am
therein (such transaction, the “Odyssey Asset Purchase”). The Purchased Assets include drug candidates for treating mild traumatic brain injury (mTBI
8-K
EX-99.1
ODYY
Odyssey Health, Inc.
13 Dec 23
Regulation FD Disclosure
5:10pm
being developed for the treatment of moderate traumatic brain injury. In preclinical studies, the drug has demonstrated equivalent, if not superior … associated with brain injury symptoms such as memory impairment, anxiety, and motor/sensory performance. Additionally, the drug is lipophilic and in pre
8-K
EX-99.1
cpr ieuhare
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
l1eb3
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
EX-2.1
ep8ikr 2kzimz
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
EX-99.1
rmzfl0gfexb2sc6aa vz
25 Nov 22
Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development
8:30am
8-K
EX-99.1
lal06
4 Nov 22
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
4:16pm
8-K
EX-10.1
zxnm 83qjc
4 Nov 22
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
4:16pm
8-K
EX-10.2
erg0z9
4 Nov 22
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
4:16pm
8-K
EX-99.1
484i1 a1mun3b
1 Nov 22
Odyssey Health Inc. Files Full US Patent Application on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device
8:45am
8-K
EX-99.1
datyvg6xa 02nxw
30 Sep 22
Odyssey Health, Inc. Makes Statement Regarding its Concussion Drug Development Program
5:51pm
8-K
EX-99.1
hwwt58i7oh9ml pwru
30 Sep 22
Odyssey Health, Inc. Announces Successful Completion of Phase I Clinical Trial for Concussion Drug
5:20pm
8-K
EX-99.1
3z8f1w8 pu
18 Aug 22
Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial
4:02pm
8-K
EX-99.1
hd3pqwam56tv vod79j4
12 Jul 22
Odyssey Health, Inc. Successfully Completes Phase I Single Ascending Dosing for Intranasal Concussion Drug
5:33pm